Drug-induced thrombocytopenia: A systematic review of published case reports

Annals of Internal Medicine

Volumn 129, Issue 11, 1998, Pages 886-890

  George, James N ^a,b   Raskob, Gary E ^a,b   Shah, Shehla Rizvi ^a,b   Rizvi, Mujahid A ^a,b   Hamilton, Stephen A ^a,c   Osborne, Scott ^a,b   Vondracek, Thomas ^a,d  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c Cancer Treatment Center   (United States)

^d Department of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AMINOGLUTETHIMIDE; AMINOSALICYLIC ACID; AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; ANTICONVULSIVE AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; AURANOFIN; AUROTHIOGLUCOSE; CARDIOVASCULAR AGENT; CONTRAST MEDIUM; CORTICOSTEROID; COTRIMOXAZOLE; DANAZOL; DEFEROXAMINE; DEFEROXAMINE MESYLATE; DICLOFENAC; DICLOFENAC POTASSIUM; DIETHYLSTILBESTROL; DIGOXIN; EFLORNITHINE; FOSFESTROL; GASTROINTESTINAL AGENT; GOLD; METHYLDOPA; NAPHAZOLINE; NOVOBIOCIN; ORAL ANTIDIABETIC AGENT; PARACETAMOL; PSYCHOTROPIC AGENT; QUINDAN; QUINIDINE; QUINIDINE GLUCONATE; QUINIDINE POLYGALACTURONATE; QUININE; QUININE SULFATE; RECOMBINANT ALPHA2A INTERFERON; RIFAMPICIN; TAMOXIFEN; TAMOXIFEN CITRATE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

BLEEDING; DISEASE COURSE; DRUG INDUCED DISEASE; EVIDENCE BASED MEDICINE; HUMAN; PRIORITY JOURNAL; REVIEW; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

EID: 0032403959     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-129-11_part_1-199812010-00009     Document Type: Review

References (18)

1. George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996;88:3-40.
2. George JN, El-Harake MA, Aster RH. Thrombocytopenia due to enhanced platelet destruction by immunologic mechanisms. In: Beutler E, Lichtman MA, Coller BS, Kipps TJ, eds. Williams Hematology. 5th ed. New York: McGraw-Hill; 1995:1315-55.
3. Warkentin TE, Kelton JG. The platelet life cycle: quantitative disorders. In: Handin RI, Lux SE, Stossel TP, eds. Blood: Principles and Practice of Hematology. Philadelphia: Lippincott; 1995:973-1048.
4. Pedersen-Bjergaard U, Andersen M, Hansen PB. Drug-induced thrombocytopenia: clinical data on 309 cases and the effect of corticosteroid therapy. Eur J Clin Pharmacol. 1997;52:183-9.
5. Drug Facts and Comparisons. 20th ed. St. Louis: Facts and Comparisons; 1997.
6. Cook DJ, Mulrow CD, Haynes RB. Systematic reviews: synthesis of best evidence for clinical decisions. Ann Intern Med. 1997;126:376-80.
7. Warkentin TE, Chong BH, Greinacher A. Heparin-induced thrombocytopenia: toward consensus. Thromb Haemost. 1998;79:1-7.
8. AHFS Drug Information. 39th ed. Bethesda, MD: American Society of Hospital Pharmacists; 1997.
9. Martindale: The Extra Pharmacopoeia (electronic version). Englewood, CO: Micromedex Inc.; 1997.
10. Graafsma YP, Prins MH, Lensing AW, de Haan RJ, Huisman MV, Buller HR. Bleeding classification in clinical trials: observer variability and clinical relevance. Thromb Haemost. 1997;78:1189-92.
11. Freiman JP. Fatal quinine-induced thrombocytopenia [Letter]. Ann Intern Med. 1990;112:308-9.
12. Kaufman DW, Kelly JP, Johannes CB, Sandler A, Harmon D, Stolley PD, et al. Acute thrombocytopenic purpura in relation to the use of drugs. Blood. 1993;82:2714-8.
13. Berkowitz SD, Harrington RA, Rund MM, Tcheng JE. Acute profound thrombocytopenia after c7E3 Fab (abciximab) therapy. Circulation. 1997;95: 809-13.
14. Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study. Lancet. 1997; 349:1429-35.
15. Deren B, Masi R, Weksler M, Nachman RL. Gold-associated thrombocytopenia. Report of six cases. Arch Intern Med. 1974;134:1012-5.
16. Coblyn JS, Weinblatt M, Holdsworth D, Glass D. Gold-induced thrombocytopenia. A clinical and immunogenetic study of twenty-three patients. Ann Intern Med. 1981;95:178-81.
17. McCrae KR, Cines DB. Drug-induced thrombocytopenias. In: Loscalzo J, Schafer AI, eds. Thrombosis and Hemorrhage. Boston: Blackwell Scientific; 1994:545-73.
18. Suh JS, Aster RH, Visentin GP. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis recognize different epitopes on heparin: platelet factor 4. Blood. 1998;91:916-22.